Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines
Journal of the European Academy of Dermatology and Venereology | Sep 05, 2021
Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies
Journal of the American Academy of Dermatology | Sep 01, 2021
Most read this week